Cargando…

High-multiplex tissue imaging in routine pathology—are we there yet?

High-multiplex tissue imaging (HMTI) approaches comprise several novel immunohistological methods that enable in-depth, spatial single-cell analysis. Over recent years, studies in tumor biology, infectious diseases, and autoimmune conditions have demonstrated the information gain accessible when map...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einhaus, Jakob, Rochwarger, Alexander, Mattern, Sven, Gaudillière, Brice, Schürch, Christian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review and Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156760/ https://www.ncbi.nlm.nih.gov/pubmed/36757500 http://dx.doi.org/10.1007/s00428-023-03509-6

Ejemplares similares

A review on deep learning applications in highly multiplexed tissue imaging data analysis
por: Zidane, Mohammed, et al.
Publicado: (2023)

Towards multiomic analysis of oral mucosal pathologies
por: Einhaus, Jakob, et al.
Publicado: (2023)

Corrigendum: A review on deep learning applications in highly multiplexed tissue imaging data analysis
por: Zidane, Mohammed, et al.
Publicado: (2023)

The Shifting Boundaries of Sustainability Science: Are We Doomed Yet?
por: Matthews, John H., et al.
Publicado: (2012)

Why Aren't We Listening Yet? A Decade of Road Safety Begins Quietly
por: Koehlmoos, Tracey Pérez
Publicado: (2013)

Invited Perspective: Air Pollution and Autism Spectrum Disorder: Are We There Yet?
por: Raz, Raanan, et al.
Publicado: (2022)

Gut Microbiota–Informed Precision Nutrition in the Generally Healthy Individual: Are We There Yet?
por: Nogal, Bartek, et al.
Publicado: (2021)

Establishing the worth of deprescribing inappropriate medications: are we there yet?
por: Scott, Ian A, et al.
Publicado: (2022)

The Molecular Pathology of Cushing Disease: Are We Nearly There?
por: Grossman, Ashley B.
Publicado: (2017)

Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging
por: Phillips, Darci, et al.
Publicado: (2021)

The Routine Utilization of Procedural Pain Management for Pediatric Lumbar Punctures: Are We There Yet?
por: Gorchynski, Julie, et al.
Publicado: (2011)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer
por: Wong, Ee Ming, et al.
Publicado: (2020)

United we stand: big roles for small RNA gene clusters
por: Felden, Brice, et al.
Publicado: (2017)

Diabetic oncopathy - One more yet another deadly diabetic complication!
por: Balasubramanyam, M.
Publicado: (2014)

Aspirin for recurrence prevention in bipolar disorder—Promising, yet clinically understudied?
por: Haarman, Bartholomeus CM, et al.
Publicado: (2018)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?
por: Danilov, Alexey V., et al.
Publicado: (2019)

Lymphatic and Blood Endothelial Extracellular Vesicles: A Story Yet to Be Written
por: Trisko, Johanna, et al.
Publicado: (2022)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction
por: Kennedy‐Darling, Julia, et al.
Publicado: (2021)

The pathology behind glaucoma: what we already know using omics technologies
por: May, Caroline, et al.
Publicado: (2023)

There is no place (yet) for routine administration of sildenafil to patients with ARDS
por: Cornet, Alexander D., et al.
Publicado: (2010)

Major and minor surgery: Terms used for hundreds of years that have yet to be defined
por: Newsome, Kevin, et al.
Publicado: (2021)

Bioengineering adult human heart tissue: How close are we?
por: Mills, Richard J., et al.
Publicado: (2019)

Nanomedicine for the poor: a lost cause or an idea whose time has yet to come?
por: Uskoković, Vuk
Publicado: (2021)

Feeling anxious yet? Interpreting findings on drug safety from large healthcare databases
por: Bushnell, Greta A., et al.
Publicado: (2022)

How Do We Explore Heterogeneity in Turnover of Musculoskeletal Proteins?
por: Agergaard, Jakob, et al.
Publicado: (2021)

The influenza A virus genome packaging network — complex, flexible and yet unsolved
por: Jakob, Celia, et al.
Publicado: (2022)

Clonal yet Different: Understanding the Causes of Genomic Heterogeneity in Microbial Species and Impacts on Public Health
por: Andam, Cheryl P.
Publicado: (2019)

Humanized mice: are we there yet?
por: Macchiarini, Francesca, et al.
Publicado: (2005)

Cancer vaccines: Are we there yet?
por: Hanna, Jr., Michael G.
Publicado: (2012)

Cancer immunotherapy: are we there yet?
por: Li, Zihai, et al.
Publicado: (2013)

Myocardial Inflammation—Are We There Yet?
por: Greulich, Simon, et al.
Publicado: (2015)

The Artificial Pancreas: Are We There Yet?
por: Cefalu, William T., et al.
Publicado: (2014)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Peak MSC—Are We There Yet?
por: Olsen, Timothy R., et al.
Publicado: (2018)

Dracunculiasis Eradication: Are We There Yet?
por: Hopkins, Donald R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2qvv0qj4tvk2scjpkfg1m4dat1